INSAN Inc. (277410.KQ) stock: key figures, P/E, revenue and dividend
Consumer Staples · South Korea
INSAN Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 32.48 bn KRW | 35.80 bn KRW |
| Gross profit | 17.97 bn KRW | 19.76 bn KRW |
| Operating income | 813.71 m KRW | 2.31 bn KRW |
| EBIT | 1.34 bn KRW | 1.09 bn KRW |
| Net income | 887.48 m KRW | 651.61 m KRW |
| Diluted EPS – continuing operations | 235.45 KRW | 172.62 KRW |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About INSAN Inc.
INSAN Inc. produces and supplies bamboo salt products in Korea and internationally. The company offers bamboo salt, bamboo salt paste types, essence types, pills, healthy food, native products, household items, and books under the Insan brand. It also provides healing programs, such as healing camps and tours; and operates training institute of Insanga. INSAN Inc. was founded in 1986 and is headquartered in Hamyang-eup, South Korea.
More stocks
- ReposiTrak, Inc. (TRAK)
- Scottie Resources Corp (SCOT.V)
- Jean Co Ltd (2442.TW)
- Epoch Chemtronics Corp. (3633.TWO)
- Kt Skylife (053210.KS)
- Definitive Healthcare Corp. (DH)
- Yuhwa Securities Co Ltd (003465.KS)
- Kwan's International Co., Ltd. (6101.TWO)
- Win Win Precision Technology Co., Ltd. (4949.TW)
- TPG Mortgage Investment Trust, Inc. (MITT)
- Cannara Biotech Inc. (LOVE.TO)
- Sinew Pharma Inc. (6634.TWO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.